Loading provider…
Loading provider…
Hematology & Oncology Physician in Oak Park, IL
NPI: 1265465728Primary Practice Location
WEST SUBURBAN MEDICAL CTR
3 ERIE COURT, Oak Park, IL
Primary Employer
Advanced Cancer Care Associates Corp
westsubmc.com
HQ Phone
Get MD Isoken's Phone NumberMobile
Get MD Isoken's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
1999 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Cook County Health and Hospitals System
Fellowship • Hematology and Medical Oncology
2001 - 2004
Residency • Internal Medicine
1996 - 1999
University of Benin Faculty of Medicine
Medical School
Until 1985
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 160 | 244 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 121 | 218 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 55 | 172 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 30 | 31 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
[Glanzmann''s thrombasthenia: first case descriptions in sub-Saharan Africa].
Authors: Dokekias, A Elira, Galiba, F O Atipo, Koko, I
Journal: Tunis Med
Authors: Dokekias, A Elira, Ossini, L Ngolet, Tsiba, F O Atipo, Malanda, F, Koko, I, De Montalembert, M
Journal: Transfus Clin Biol
Publication Date: 2009-04-14
[Description of a peculiar form of Hodgkin''s disease associated with Epstein-Barr virus infection].
Authors: Elira Dokekias, A, Koko, I, Atipo Galiba, F O, Martin, A
Journal: Bull Soc Pathol Exot
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Pembrolizumab, DRUG: Pemetrexed, OTHER: Comprehensive Geriatric Assessment
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Oxaliplatin, DRUG: Duloxetine, DRUG: Duloxetine Hydrochloride